ES2108855T3 - Derivados de acido oxamico como agentes hipocolesteremicos. - Google Patents

Derivados de acido oxamico como agentes hipocolesteremicos.

Info

Publication number
ES2108855T3
ES2108855T3 ES93810495T ES93810495T ES2108855T3 ES 2108855 T3 ES2108855 T3 ES 2108855T3 ES 93810495 T ES93810495 T ES 93810495T ES 93810495 T ES93810495 T ES 93810495T ES 2108855 T3 ES2108855 T3 ES 2108855T3
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
lower alkyl
halogen
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810495T
Other languages
English (en)
Inventor
Naokata Yokoyama
Gordon Northrop Walker
Alan Joseph Main
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2108855T3 publication Critical patent/ES2108855T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
    • C07C323/35—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
    • C07C323/37—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group the sulfur atom of the sulfide group being further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

SE DESCUBREN COMPUESTOS DE FORMULA EN DONDE R ES HIDROGENO, HIDROXILO, HIDROXILO ESTERIFICADO O HIDROXILO ETERIFICADO; R1 ES HIDROGENO, HALOGENO, TRIFLUOROMETILO O ALQUILO INFERIOR; R2 ES HIDROGENO, HALOGENO, TRIFLUOROMETILO O ALQUILO INFERIOR; R3 ES HALOGENO, TRIFLUOROMETILO, ALQUILO INFERIOR, ARILO, ALQUILO ARILO INFERIOR, CICLOALQUILO O ALQUILO CICLOALQUILO INFERIOR; O R3 ES EL RADICAL EN DONDE R8 ES HIDROGENO, ALQUILO INFERIOR, ARILO, CICLOALQUILO, ALQUILO ARILO INFERIOR O ALQUILO CICLOALQUILO INFERIOR; R9 ES HIDROXILO O ACILOXILO; R10 REPRESENTA HIDROGENO O ALQUILO INFERIOR; O R9 Y R10 JUNTOS REPRESENTAN OXO; R4 ES HIDROGENO, HALOGENO, TRIFLUOROMETILO O ALQUILO INFERIOR; X ES -NR7; W ES O O S; R5 Y R6 JUNTOS REPRESENTAN OXO; R7 REPRESENTA HIDROGENO O ALQUILO INFERIOR; Z REPRESENTA CARBOXILO, DERIVADO DE CARBOXILO COMO UN ESTER FARMACEUTICAMENTE ACEPTABLE O COMO UNA AMIDA FARMACEUTICAMENTE ACEPTABLE; Y SALES DE ELLOS FARMACEUTICAMENTE ACEPTABLES; LOS CUALES SE USAN COMO AGENTES HIPOCOLESTEREMICOS.
ES93810495T 1992-07-21 1993-07-12 Derivados de acido oxamico como agentes hipocolesteremicos. Expired - Lifetime ES2108855T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91854492A 1992-07-21 1992-07-21

Publications (1)

Publication Number Publication Date
ES2108855T3 true ES2108855T3 (es) 1998-01-01

Family

ID=25440554

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810495T Expired - Lifetime ES2108855T3 (es) 1992-07-21 1993-07-12 Derivados de acido oxamico como agentes hipocolesteremicos.

Country Status (19)

Country Link
US (3) US5401772A (es)
EP (1) EP0580550B1 (es)
JP (1) JP3616119B2 (es)
KR (1) KR100294381B1 (es)
AT (1) ATE159515T1 (es)
AU (1) AU667924B2 (es)
CA (1) CA2100817C (es)
DE (1) DE69314718T2 (es)
DK (1) DK0580550T3 (es)
ES (1) ES2108855T3 (es)
FI (1) FI114633B (es)
GR (1) GR3025517T3 (es)
HU (1) HU214875B (es)
IL (1) IL106360A0 (es)
NO (1) NO304111B1 (es)
NZ (1) NZ248181A (es)
SA (1) SA94140579B1 (es)
TW (1) TW350771B (es)
ZA (1) ZA935196B (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646330A (en) * 1995-02-17 1997-07-08 Ciba-Geigy Corporation Production of enantiomerically enriched ortho-substituted α,α-diaromatic methanols
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5698732A (en) * 1997-01-13 1997-12-16 General Electric Company Oxanilide U-V absorbers
WO1999007703A1 (en) 1997-08-05 1999-02-18 Pfizer Products Inc. 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
GB9816935D0 (en) * 1998-08-05 1998-09-30 Karobio Ab Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
WO2000051971A1 (en) 1999-03-01 2000-09-08 Pfizer Products Inc. Oxamic acids and derivatives as thyroid receptor ligands
US6344481B1 (en) * 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
DE60018225T2 (de) 1999-03-01 2005-12-29 Pfizer Products Inc., Groton Oxamsäuren mit einer Cyanogruppe als Liganden für den Thyroidrezeptor
US6790978B2 (en) 1999-03-29 2004-09-14 Novartis Ag Thyromimetic organic compounds
US6599942B1 (en) 1999-03-29 2003-07-29 Novartis Ag Thyromimetic organic compounds
CO5160290A1 (es) * 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
JP2003500432A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
EP1194422A1 (en) * 1999-06-01 2002-04-10 University Of Texas Southwestern Medical Center Biaryl compounds
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
MXPA01012494A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
AU3507600A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Substituted biaryl ether compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
EP1127882A1 (en) * 2000-01-25 2001-08-29 Pfizer Products Inc. Tetrazole compounds as thyroid receptor ligands
PL201790B1 (pl) 2000-02-17 2009-05-29 Bristol Myers Squibb Co Anilinopochodny ligand dla receptora tarczycy, jego zastosowanie i kompozycja farmaceutyczna
US6664291B2 (en) 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
KR20020089420A (ko) * 2000-03-31 2002-11-29 화이자 프로덕츠 인코포레이티드 갑상선 수용체 리간드로서의 말로남산 및 그의 유도체
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
AU4884701A (en) * 2000-05-12 2001-11-20 Kissei Pharmaceutical Co. Ltd. Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
DE10024939A1 (de) * 2000-05-19 2001-11-29 Bayer Ag Neue Diphenylmethanderivate für Arzneimittel
US6395784B1 (en) 2000-06-07 2002-05-28 Bristol-Myers Squibb Company Benzamide ligands for the thyroid receptor
GB0015205D0 (en) * 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
DE10038007A1 (de) * 2000-08-04 2002-02-14 Bayer Ag Neue Amino-und Amido-Diphenylether für Arzneimittel
US6680340B2 (en) * 2000-08-21 2004-01-20 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
DE10046029A1 (de) 2000-09-18 2002-03-28 Bayer Ag Indazole
WO2002046137A1 (fr) * 2000-12-07 2002-06-13 Mitsui Chemicals, Inc. Procede de production d'un compose halogenobenzene substitue
WO2002051805A1 (de) 2000-12-27 2002-07-04 Bayer Aktiengesellschaft Indol-derivate
US6777442B2 (en) 2001-03-12 2004-08-17 Bayer Aktiengesellschaft Diphenyl derivatives
US6462168B1 (en) 2001-04-25 2002-10-08 General Electric Company Weatherable polycarbonates comprising oxanilide structural units, method, and articles made therefrom
US6777443B2 (en) 2001-05-15 2004-08-17 Novartis Ag Dipeptide derivatives
WO2002094319A1 (en) * 2001-05-18 2002-11-28 Kissei Pharmaceutical Co., Ltd. Preventive or recurrence-suppressive agents for liver cancer
AU2002336959B2 (en) * 2001-08-10 2006-07-13 Novartis Ag Peptides that bind to atherosclerotic lesions
KR20040027927A (ko) * 2001-08-24 2004-04-01 카로 바이오 아베 심장 및 대사 장애의 치료를 위해 주요 환이 치환된갑상선 수용체 길항근
DE60208132T2 (de) 2001-09-26 2006-07-20 Pfizer Products Inc., Groton Indolcaroboxylsäure als Thyroidrezeptor-Liganden
US6806381B2 (en) * 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
CN100366659C (zh) * 2002-07-05 2008-02-06 通用电气公司 含n,n′-草酰二苯胺结构单元的耐气候性聚碳酸酯、其制造方法及由其制得的制品
GB0215978D0 (en) * 2002-07-10 2002-08-21 Karobio Ab Novel compounds
TW200504021A (en) * 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
WO2004066929A2 (en) * 2003-01-24 2004-08-12 Bristol-Myers Squibb Company Cycloalkyl containing anilide ligands for the thyroid receptor
US7557143B2 (en) 2003-04-18 2009-07-07 Bristol-Myers Squibb Company Thyroid receptor ligands
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US8188277B2 (en) 2004-08-06 2012-05-29 Otsuka Pharmaceutical Co., Ltd. Aromatic compounds for suppressing the generation of collagen
ES2328384T3 (es) * 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
RU2007148927A (ru) * 2005-05-26 2009-07-10 Метабэйзис Терапьютикс, Инк. (Us) Новые тиреомиметики, содержащие фосфиновую кислоту
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
WO2007002036A1 (en) * 2005-06-24 2007-01-04 Thomas Lavin Tyroid hormone in burn and adipose deposites
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP1957073B1 (en) 2005-12-05 2014-04-23 Otsuka Pharmaceutical Co., Ltd. Medicinal drug
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
DK2695611T3 (en) * 2012-08-06 2015-01-05 Wolff August Gmbh & Co Kg Arzneimittel Dr Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions
CN104193699B (zh) * 2014-08-14 2016-05-25 嘉兴特科罗生物科技有限公司 一种小分子化合物及其合成方法和应用
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
EP4775207A2 (en) 2018-12-05 2026-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EP4161925A4 (en) 2020-06-09 2024-09-04 Viking Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500260A (de) * 1967-05-16 1971-01-29 Ciba Geigy Ag Verwendung von Bis-oxalsäure-esteramiden als Stabilisierungsmittel ausserhalb der Textilindustrie
DE2223894C3 (de) * 1972-05-17 1981-07-23 Hoechst Ag, 6000 Frankfurt Herbizide Mittel auf Basis von Phenoxycarbonsäurederivaten
DE2303239A1 (de) * 1973-01-24 1974-07-25 Reichhold Albert Chemie Ag Verfahren zur herstellung von modifizierten, amid- und/oder imidgruppen enthaltenden n,n'-substituierten 2,4,5triketoimidazolidinen
US4191840A (en) * 1973-03-23 1980-03-04 American Home Products Corporation Oxamic acid derivatives
US4154961A (en) * 1973-03-23 1979-05-15 American Home Products Corporation Oxamic acid derivatives
US4036837A (en) * 1973-03-23 1977-07-19 American Home Products Corporation 2 Alkoxyoxamoyl-pyrazines
US3903053A (en) * 1973-11-20 1975-09-02 Teijin Ltd Process for the preparation of polymers containing divalent hydantoin rings in their main chains
CS185694B2 (en) * 1974-07-17 1978-10-31 Ishihara Sangyo Kaisha Herbicidal agent
CH609024A5 (en) * 1974-09-30 1979-02-15 Lafon Labor Process for the preparation of new sulphur-containing diaryl and oxygen-containing diaryl compounds
US4061791A (en) * 1975-12-29 1977-12-06 The Upjohn Company Anti-allergic oxanilate compounds
DE2623558C2 (de) * 1976-05-26 1984-12-06 Hoechst Ag, 6230 Frankfurt 2-[4'-Phenoxy-phenoxy]propionsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende herbizide Mittel
US4137325A (en) * 1977-03-17 1979-01-30 American Home Products Corporation Antisecretory oxamic acid esters
GB1572527A (en) * 1977-05-05 1980-07-30 Ici Ltd Method of controlling pollen formation
CH650493A5 (en) * 1977-12-24 1985-07-31 Hoechst Ag D-(+)-alpha-phenoxypropionic acid derivatives
DE3480199D1 (de) * 1983-08-26 1989-11-23 Ciba Geigy Ag Oxalic-acid anilides
US4642338A (en) * 1983-09-01 1987-02-10 The Dow Chemical Company Fluorophenoxyphenoxypropionates and derivatives thereof
GB8501372D0 (en) * 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
CA1257598A (en) * 1987-08-11 1989-07-18 Harukazu Fukami Herbicidally active phenoxyalkanecarboxylic acid derivatives

Also Published As

Publication number Publication date
US5569674A (en) 1996-10-29
HUT64512A (en) 1994-01-28
DE69314718D1 (de) 1997-11-27
FI933260A0 (fi) 1993-07-19
KR100294381B1 (ko) 2001-09-17
NO932614D0 (no) 1993-07-20
TW350771B (en) 1999-01-21
DE69314718T2 (de) 1998-02-26
NO932614L (no) 1994-01-24
ZA935196B (en) 1994-07-07
FI114633B (fi) 2004-11-30
JPH06172275A (ja) 1994-06-21
IL106360A0 (en) 1993-11-15
JP3616119B2 (ja) 2005-02-02
KR940005555A (ko) 1994-03-21
HU214875B (hu) 1998-07-28
CA2100817C (en) 2004-10-12
US5654468A (en) 1997-08-05
NO304111B1 (no) 1998-10-26
SA94140579B1 (ar) 2006-07-10
GR3025517T3 (en) 1998-02-27
HU9302095D0 (en) 1993-10-28
US5401772A (en) 1995-03-28
EP0580550B1 (en) 1997-10-22
FI933260A7 (fi) 1994-01-22
AU667924B2 (en) 1996-04-18
DK0580550T3 (da) 1998-02-02
AU4208193A (en) 1994-01-27
ATE159515T1 (de) 1997-11-15
EP0580550A1 (en) 1994-01-26
NZ248181A (en) 1995-11-27
CA2100817A1 (en) 1994-01-22

Similar Documents

Publication Publication Date Title
AU667924B2 (en) Heteroacetic acid derivatives
DE19575041I2 (de) Substituierte Acyl-Derivate von 1, 2, 3, 4-Tetrahydro-6, 7-dimethoxy-3-isoquinolin-Carbonsaeure
NO862621L (no) Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater.
NO934536D0 (no) Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler
FI933213A0 (fi) Nya piperidinderivat av bensimidazolin
ES2156853T3 (es) Derivados de quinolina.
ES2063756T3 (es) Derivados de acido benzoilaminofenoxibutanoico.
FI830810A0 (fi) Pyridinkarboxylsyraestrar, foerfarande foer deras framstaellning och deras anvaendning som laekemed
AR027578A1 (es) Derivados de indano
CO5011117A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos y procedimiento para su preparacion .
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
ES8306741A1 (es) "un procedimiento para la preparacion de 4-(4-imidazolil)-piridinas 2-sustituidas".
NO157931C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(4-(difenylmethylen)-1-piperidinyl)-eddiksyrer samt deres amider og salter.
ES8706634A1 (es) Procedimiento para la obtencion de compuestos de amida
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ES2181321T3 (es) Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
MX9706187A (es) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580550

Country of ref document: ES